Table 1.
Flavonoid | Mitochondrial Disorder | Study Design | Effects | Ref |
---|---|---|---|---|
Cancers | ||||
Apigenin | colon cancer | HCT116, HT29, and DLD1 colon cancer cells | ↓ PKM2 activity and expression, ↓ PKM2/PKM1 ratio, blocked β-catenin/c-Myc/PTBP1 | [105] |
Quercetin | breast cancer | MCF-7 and MDA-MB-231 human breast cancer cell lines; murine MCF-7 xenografts | ↓ PKM2, ↓ GLUT1, ↓ LDHA, ↓ p-Akt/Akt | [106] |
Shikonin | lung carcinoma and melanoma | Lewis lung carcinoma and B16 melanoma cells | ↓ glucose uptake, ↓ lactate production, ↓ tumor cell ATP production, ↓ PKM2 | [107] |
Xanthohumol | colorectal cancer | HT29, SW480, LOVO, HCT116, and SW620 colorectal cancer cell lines | ↓ HK2, ↓ glycolysis, ↑ cytochrome c, ↑ intrinsic (mitochondrial) apoptotic pathway | [13] |
Glioma | rat glioma C6 cells | ↓ proliferation, ↑ apoptosis, ↑ AIF | [111] | |
Licochalcone | colorectal cancer, non-small cell lung carcinoma, and primary bronchioalveolar carcinoma | HCT116 colorectal cancer, H1299 non-small cell lung carcinoma, and H322 primary bronchioalveolar carcinoma cells. | ↓ HIF-1α, ↓ GLUT1, ↓ PDK1, ↑ intracellular oxygen content, ↓ mitochondrial respiration | [113] |
EGCG | breast cancer | 4T1 mouse breast cancer cells | ↓ glucose, ↓ lactate, ↓ ATP levels, ↓ HIF1α, ↓ GLUT1, ↑ mitochondrial depolarization, ↓ HK, ↓ phosphofructokinase, ↓ LDH, ↓ PK | [14] |
Albanol B | lung cancer | A549, BZR, H1975, and H226 human lung cancer cell lines | ↑ mtROS production, ↑ phosphorylation of Akt, ↑ phosphorylation of ERK1/2, ↑ apoptosis, ↑ cell cycle arrest at G2/M phase | [114] |
Lysionotin | liver cancer | HepG2 and SMMC-7721 cells and HepG2 and SMMC-7721-xenoghraft tumor mouse model | ↑ mitochondrial apoptosis pathway, ↑ caspase 3, control oxidative stress | [115] |
BAS-4 | Glioma | C6 glioma cells | ↑ apoptosis, loss of mitochondrial membrane potential, Akt pathway disruption | [116] |
Isoquercetin | Melanoma | SK-Mel-2 human melanoma cells | ↑ mitochondrial apoptosis, ↓ procaspase-8 and -9, ↓ Bcl-2 protein, ↑ cleaved caspase, ↑ Bax, ↑ AIF, ↑ Endo G, ↓ PI3K/Akt/mTOR signaling | [117] |
Myricetin | lung cancer | in vitro (A549 lung cancer cells) and in silico study | ↑ cell cycle arrest, ↑ ROS-reliant mitochondrial apoptosis | [118] |
Silibinin | oral squamous carcinoma | SCC-25 human oral squamous carcinoma cells | ↑ apoptosis, ↑ cytochrome c, ↑ caspase-3 and -9 | [119] |
Cardiovascular Diseases | ||||
Extract of Aronia melanocarpa | cardiovascular disease | 50 μg/mL of Aronia Melanocarpa fruit extract in human aortic endothelial cells | ↑ NF-κB, ↑ ROS production | [121] |
Cornelian cherry fruits | hypertriglicerydemia and atherosclerosis | diet-induced hypertriglicerydemia and atherosclerosis in a New Zealand rabbit model | ↓ serum triglyceride levels, ↑ PPARα protein expression | [123] |
Naringenin | myocardial ischemia-reperfusion injury | Sprague-Dawley rats and H9c2 cardiomyoblasts | ↓ mitochondrial oxidative stress damage, ↓ mitochondrial cytochrome c release, ↓ oxidative markers, ↑ mitochondrial biogenesis, ↑ NRF1, ↑ TFAM, ↑ OXPHOS II, III and IV subunits, ↓ myocardial ischemia-reperfusion injury | [15] |
Naringin | cardiomyocyte hypertrophy | H9c2 rat myoblasts after fructose exposure, high fructose-induced cardiac hypertrophy | ↓ mtROS production, ↓ cardiomyocyte hypertrophy, ↓ AMPK-mTOR | [124] |
7,8-Dihydroxyflavone | myocardial ischemia | adult Kunming mice, H2O2-treated H9c2 Rattus norvegicus myoblasts | ↓ mitochondrial fission, ↓ Fis-1, ↑ mitochondrial membrane potential, ↓ mitochondrial superoxide, ↓ OPA1 | [126] |
heart disease | doxorubicin—induced cardiotoxicity in Kunming mice; H9c2 cells | ↑ cardiac function, ↓ cardiac injury, ↑ OXPHOS, ↑ mitochondrial membrane potential, ↑ Akt activation, ↑ OPA1 | [127] | |
Dihydromyricetin | diabetic cardiomyopathy | streptozotocin—induced diabetic C57BL/6J mice; dihydromyricetin treatment at 100 mg/kg/day | ↑ ATP content, ↑ citrate synthase activity, ↑ complex Ι, ΙΙ, ΙΙΙ, ΙV, and V activities | [128] |
Quercetin | cardiac hypertrophy | isoproterenol—induced cardiac hypertrophy in male Swiss mice | ↑ protein sulfhydryls, ↑ superoxide dismutase activity, ↓ opening of mitochondrial permeability transition pore | [129] |
Luteolin | sepsis-induced cardiomyopathy | intraperitoneal injection of luteolin in male C57BL/6 mice; lipopolysaccharide—induced myocardial injury | ↓ mitochondrial injury, ↓ oxidative stress, ↓ phosphorylation of AMPK in septic heart tissue, ↓ destabilized mitochondrial membrane potential | [16] |
Icariin | cardiac oxidative stress injury | H9C2 cardiac myocytes; H2O2—induced oxidative stress injury | ↑ ROS scavenging, phosphorylation of ERK pathway, maintenance of Ca2+ homeostasis, prevention of mitochondrial membrane potential dissipation | [130] |
Cyanidin | sepsis and myocardial oxidative or inflammation-induced injury | lipopolysaccharide—induced myocardial injury in male/female C57BL/6 mice | ↑ mitochondrial function, ↓ oxidative damage, ↓ Opa1, ↓ Trx1 | [131] |
Tilialin | myocardial ischemia/reperfusion injury | oxygen-glucose deprivation/reperfusion-injured H9c2 cardiomyocytes; ischemia/reperfusion- (I/R-) injured isolated rat hearts | ↑ CaMKII-mediated mitochondrial apoptosis, ↑ JNK/NF-κB inflammation | [132] |
Fisetin | acute myocardial infarction | in vitro (cardiomyocytes), in vivo (rat heart model), and in silico experiment | ↓ mitochondrial oxidative stress, ↓ mitochondrial dysfunction, ↓ GSK3β activity | [133] |
ischemia/reperfusion injury | Male Wistar rat model | ↓ myocardial infarct size, apoptosis, lactate dehydrogenase, and creatine kinase in serum/perfusate, ↑ PI3K activation | [134] | |
Baicalin | myocardial injury after cardiac arrest | Cardiac arrest-induced injury in male Sprague-Dawley rats | ↓ mitochondrial dysfunction, ↑ cardioprotective effect, ↓ phosphorylation at serine 616 and translocation of Drp1, and excessive fission of mitochondria | [135] |
Neurodegenerative Disorders | ||||
Naringin | neurodegenerative disorders and neurotoxicity | Six-week administration of aluminum (100 mg/kg) and naringin (40 and 80 mg/kg) to male Wistar rats | ↑ cognitive performance, ↓ mitochondrial oxidative damage, ↓ NADH dehydrogenase, ↓ succinate dehydrogenase, ↓ cytochrome oxidase | [137] |
Quercetin | AD | Quercetin injection every 48 h for 3 months (25 mg/kg) in a murine triple transgenic AD model (3xTg-AD) | ↓ Aβ, ↓ BACE1-mediated cleavage of APP | [139] |
H2O2—induced neuronal toxicity and Aβ—induced neurodegeneration of hippocampal neurons | ↓ ROS, ↑ recovery of normal mitochondrial morphology | [140] | ||
EGCG | meta-analysis of 17 preclinical studies; animal models | ↓ Aβ42 level, ↓ acetylcholinesterase activity, ↓ tau phosphorylation, anti-oxidation, anti-inflammation, anti-apoptosis, ↑ α-, β-, and γ-secretase activity | [146] | |
Isoquercitrin | streptozotocin—induced mitochondrial dysfunction and oxidative stress in murine Neuro-2a neuroblastoma cells | ↑ mitochondrial function, ↑ mitochondrial membrane potential, ↓ VDAC, ↓ mtROS | [18] | |
Mangiferin and morin | Aβ—induced mitochondrial impairments in cortical neurons from E18 Sprague-Dawley rat embryos | ↓ mitochondrial impairments, ↑ respiratory capacity, ↓ mitochondrial membrane depolarization, ↓ cytochrome c release | [147] | |
Quercetin | PD | Murine MN9D dopaminergic cells; 6-hydroxydopamine—induced neurotoxicity | ↑ phosphorylation of PKD1, Akt, CREB, BDNF; ↑ mitochondrial bioenergetics capacity | [143] |
6-hydroxydopamine—treated PC12 rat pheochromocytoma cells; 6-hydroxydopamine—lesioned rat model of PD | ↑ mitochondrial quality control, ↓ oxidative stress, ↑ Parkin, ↑ PINK1, ↓ α-syn | [148] | ||
rotenone—induced rat model (inbred adult Sprague–Dawley rats) | ↑ mitochondrial complex-I activity, ↓ ROS | [17] | ||
Myricitrin | PC12 rat adrenal gland cells, 6-OHDA—induced mitochondrial damage and neurotoxicity | ↓ mitochondrial damage, ↓ mitochondrial oxidation, ↓ ROS, ↓ lipid peroxidation | [149] | |
1-methyl-4-phenylpyridinium—induced mitochondrial dysfunction in SN4741 substantia nigra dopaminergic cells | ↑ maintenance of mitochondrial function, ↑ DJ-1 | [150] | ||
Hesperidin | rotenone—induced apoptosis in SK-N-SH neuroblastoma cells | ↑ maintenance of mitochondrial function | [151] | |
Tilialin | cerebral ischemia | oxygen-glucose deprivation protocol; in silico docking mode and SH-SY5Y human-derived thrice cloned cell line | ↑ mitochondrial function, ↓ inflammation, ↓ CaMKII-dependent mitochondrion-mediated apoptosis, ↓ MAPK/NF-κB inflammatory activation | [152] |
Hydroxysafflor yellow A | ischemia/reperfusion injury | PC12 rat adrenal gland cells | ↓ ROS, ↓ suppress cellular apoptosis, ↓ phenylalanine levels, ↑ mitochondrial function, ↑ upregulation of mitochondrial fission protein Drp1 | [153] |
cerebral ischemia/reperfusion injury | male Sprague Dawley rats | ↑ brain microvascular endothelial cells viability, ↓ ROS, ↓ opening of mitochondrial permeability transition pore, ↓ translocation of cytochrome c, ↑ phosphorylation of ERK, ↓ cyclophilin D | [154] | |
Nobiletin | mitochondrial dysfunction in AD and PD | mitochondrial dysfunction mediated by the ETC system downregulation by hindering complex I and III in cortical neurons of rats | ↓ mtROS, ↓ apoptosis, ↑ ATP production, ↑ neuronal viability, ↓ translocation of AIF, ↑ complex I, ↑ Nrf2, ↑ HO-1 | [155] |
Explanatory notes: ↑ increased/improved, ↓ decreased/inhibited. Abbreviations: PKM2, protein kinase M2; c-Myc, MYC proto-oncogene; PTBP1, polypyrimidine tract binding protein 1; GLUT1, glucose transporter 1; LDHA, lactate dehydrogenase A; Akt, serine/threonine-protein kinases; ATP, adenosine triphosphate; HK2, hexokinase 2; HIF-1α, hypoxia-inducible factor 1-alpha; PDK1, phosphoinositide-dependent kinase-1; LDH, lactate dehydrogenase; PK, protein kinase; mtROS, mitochondrial reactive oxygen species; ERK1/2, extracellular signal-regulated kinases 1/2; NF-κB, nuclear factor-κB; PPARα, peroxisome proliferator-activated receptor α; NRF1, nuclear respiratory factor 1; TFAM, transcription factor A mitochondrial; OXPHOS, oxidative phosphorylation; AMPK, 5’ AMP-activated protein kinase; mTOR, mechanistic target of rapamycin; Fis-1, mitochondrial fission 1 protein; OPA1, mitochondrial dynamin like GTPase; Trx1, thioredoxin; NADH, nicotinamide adenine dinucleotide hydrogen; Aβ, amyloid beta; BACE1, beta-site APP cleaving enzyme 1; APP, amyloid-beta precursor protein; CREB, cAMP-response element binding protein; BDNF; brain-derived neurotrophic factor; tau, microtubule associated protein; AD, Alzheimer’s diseasAbbreviationse; PD, Parkinson’s disease, EGCG, epigallocatechin-3-gallate; H2O2, hydrogen peroxide; AIF, apoptosis-inducing factor; GSK3β, glycogen synthase kinase 3β; HO-1, heme oxygenase 1; CaMKII, Ca2+/calmodulin-dependent protein kinase II; Nrf2, nuclear factor erythroid 2–related factor 2; Drp1, dynamin-related protein; JNK, c-Jun N-terminal kinase.